DEFINITIONS T1/2 & Tmax Cmax AUC 1st order kinetics

Slides:



Advertisements
Similar presentations
Instant Clinical Pharmacology E.J. Begg
Advertisements

First, zero, pseudo-zero order elimination Clearance
Pages 645 to 724 Mechanisms of Drug Interaction Pharmacokinetic –Reduced rate and/or completeness of absorption –Altered bioavailabilty –Reduced.
PHARMACOKINETIC.
Pharmacokinetics Ampicillin Ceftriaxone Vancomycin Half-Life: hr
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Pharmacokinetics -- part 1 --
Definitions Pharmacokinetics –The process by which a drug is administered, absorbed, distributed, bound, inactivated, metabolized and eliminated by the.
Pharmacokinetics of Drug Absorption
Nonlinear pharmacokinetics
Pharmacokinetics & Pharmacodynamics of Controlled Release Systems Presented By: Govardhan.P Dept. of pharmaceutics, University College of Pharmaceutical.
One-compartment open model: Intravenous bolus administration
Multiple IV Dosing Pharmacokinetic Research, Bioequivalence Studies,
Week 3 - Biopharmaceutics and Pharmacokinetics
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
INTRAVENOUS INFUSION.
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PHARMACOKINETICS 1. Fate of drugs in the body 1.1 absorption
Objective: Explain the variation in dosing intervals for medications 1)Introduce Half-Life (t 1/2 ) 2)Relate Half-Life to Dosing intervals of aspirin and.
You have learned a LOT so far. A few extra facts to throw in No single reproducible abnormality in any NT, enzyme, receptor or gene has been found to.
Pharmacokinetics Introduction
10/13/20151Prof. Mazen Qato. OBJECTIVES 10/13/2015Prof. Mazen Qato2.
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
Fundamentals of Drug Action
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Multiple Dosing: Intermittent or multiple dose regimen
Pharmacokinetics of strong opioids Susan Addie Specialist palliative care pharmacist.
 all drugs not in gaseous state need to use fluid routes of excretion ◦ fluid routes include -sweat, tears, saliva, mucous, urine, bile, human milk ◦
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
Core Concepts in Pharmacology Chapter 5 Pharmacokinetics.
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
The General Concepts of Pharmacokinetics and Pharmacodynamics
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
PHARMACOKINETICS INTRODUCTION
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
Continuous intravenous infusion (one-compartment model)
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
INTRODUCTION CLINICAL PHARMACOKINETICS
BIOPHARMACEUTICS.
1 Pharmacokinetics: Introduction Dr Mohammad Issa.
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
TDM Therapeutic Drug Monitoring
The General Concepts of Pharmacokinetics and Pharmacodynamics
Dr. Laila M. Matalqah Ph.D. Pharmacology Pharmacodynamics 2 General Pharmacology M212.
415 PHT Plasma Level – Time Curve
Clinical Pharmacokinetics. Time course Duration Onset Absorptive phase Elimination phase.
INTRODUCTION TO PHARMACOKINETICS M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague, Charles University in Prague,
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
MULTIPLE DOSAGE REGIMEN
Drug Response Relationships
Pharmacology Phone Number: (203)
Excretion of drugs.
Chapter 7 COMPARTMENT MODELS
Applications of Pharmacokinetics
Clinical Pharmacokinetics
School of Pharmacy, University of Nizwa
INTRODUCTION to Pharmacology
Pharmacologic Principles – Chapter 2
1 Concentration-time curve
School of Pharmacy, University of Nizwa
Therapeutic Drug Monitoring chapter 1 part 1
Introduction to Pharmacology
Section 1. Basic Principles of Pharmacology
Objectives To discuss what happens after drug administration
Presentation transcript:

DEFINITIONS T1/2 & Tmax Cmax AUC 1st order kinetics Zero order kinetics Steady state (enteric coated, longer T1/2) Loading doses Therapeutic index

Maximum plasma concentration achieved Amount of drugs in plasma = Bioavailability Time to maximum peak plasma concentration Area of plasma concentration to fall by half Only applies to drugs with first order kinetics

Distribution leads to a fall in plasma concentration / achieving equilibrium within different compartments. Vd=Q/C. When Vd is high = high affinity for lipophilic tissues seen in psychotropic drugs

1-Rate of elimination independent of the amount of drug present 2-e.g fixed IV infusions, alcohol, absorption from depot 3-There is no fixed half-life 1-Applies to most drugs 2-Rate of elimination depends of the amounts of the drug present 3-Amount of the drugs eliminated in each half-life differs

ELIMINATION Excretion by kidneys most important Li+: most important; What is the effect of Na+ Urinary pH: important for barbiturates Age Renal impairment Also through bile or through skin

Steady state: after repeated dosage leading to an equilibrium between absorption and elimination Depends on dose, time between dose and elimination half life Achieved after 4-5 half life Loading dosage can be given to achieve therapeutic plasma concentration Therapeutic Index: Is the minimum plasma drug concentration causing toxic effect to that causing therapeutic effect

PHARMACODYNAMICS Level of actions Examples Re-uptake Mechanism of action of drugs “The effect of the drug on the body” Usually there is a neurotransmitter or various involved. The therapeutic effect appears to depend on the neurotransmitter that is involved (also the Side effects) Effect can occur at various levels Level of actions Examples Re-uptake TCA, SSRI, Cocaine Pre synaptic Lofexidine at alpha 2 Post synaptic D2 blockers antipsychotics Partial agonist Aripiprazole / Buprenorphine antagonist Flumazenil Full agonist Bzd at GABA complex Second messenger Lithium at inositol level